ISR Share Price

Open 0.60 Change Price %
High 0.60 1 Day -0.03 -5.08
Low 0.56 1 Week 0.00 0.00
Close 0.56 1 Month 0.00 0.00
Volume 62202 1 Year -0.33 -37.08
52 Week High 1.06
52 Week Low 0.48
ISR Important Levels
Resistance 2 0.60
Resistance 1 0.58
Pivot 0.57
Support 1 0.54
Support 2 0.52
AMEX USA Most Active Stocks
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
CVM 0.12 9.09%
CVM 0.12 9.09%
RBY 0.03 -70.00%
PBTH 8.23 0.37%
NGD 3.00 1.01%
NGD 3.00 1.01%
GGR 0.02 100.00%
More..
AMEX USA Top Gainers Stocks
TTTM 0.02 100.00%
GGR 0.02 100.00%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
MBA 0.20 25.00%
MBA 0.20 25.00%
MBA 0.20 25.00%
IG 7.68 22.49%
More..
AMEX USA Top Losers Stocks
RBY 0.03 -70.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
QBC 0.20 -33.33%
ATL 0.06 -25.00%
ATL 0.06 -25.00%
SNT 0.12 -20.00%
CMFO 0.04 -20.00%
INV 0.14 -17.65%
More..

IsoRay, Inc. (AMEX: ISR)

ISR Technical Analysis 4
As on 22nd May 2017 ISR Share Price closed @ 0.56 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.65 & Sell for SHORT-TERM with Stoploss of 0.57 we also expect STOCK to react on Following IMPORTANT LEVELS.
ISR Target for May
1st Target up-side 0.68
2nd Target up-side 0.73
3rd Target up-side 0.78
1st Target down-side 0.54
2nd Target down-side 0.49
3rd Target down-side 0.44
ISR Other Details
Segment EQ
Market Capital 20927304.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website http://www.isoray.com
ISR Address
ISR
350 Hills Street
Suite 106
Richland, WA 99354
United States
Phone: 509-375-1202
ISR Latest News
Heady Investors are Taking a Look at IsoRay, Inc. (:ISR)   Morgan Research   - 22nd May 17
The Maxim Group Analysts Give IsoRay, Inc. (ISR) a $3.00 Price Target   BangaloreWeekly   - 22nd May 17
IsoRay Announces Study Accepted for Publication in The International Journal ...   PR Newswire (press release)   - 03rd May 17
IsoRay, Inc. to Present at the Planet MicroCap Showcase 2017   Yahoo Finance   - 18th Apr 17
IsoRay, Inc. Announces the Launch of a Pilot Study Using Intraoperative ...   PR Newswire (press release)   - 21st Dec 16
IsoRay, Inc. Enters Into Agreement to Settle Class Action Shareholder Litigation   PR Newswire (press release)   - 27th Sep 16
IsoRay Boosted By Brain Brachytherapy   Seeking Alpha   - 22nd Jun 16
IsoRay Appoints Thomas LaVoy as CEO to Take Office on February 15   PR Newswire (press release)   - 14th Jan 16
Why IsoRay Presents A Very Compelling Risk/Reward Opportunity   Seeking Alpha   - 14th Mar 14
0.59   MarketWatch   - 22nd Dec 09
Interactive Technical Analysis Chart IsoRay, Inc. ( ISR AMEX USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on IsoRay, Inc.
ISR Business Profile
IsoRay, Inc develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases primarily in the United States. The company produces Proxcelan Cesium-131 brachytherapy seeds that are used for the treatment of prostate, lung, head and neck, colorectal, brain, pelvic/abdominal, and gynecological cancers, as well as ocular melanoma. It also offers GliaSite radiation therapy system, a balloon catheter device, which is used to treat brain cancer, including primary and recurrent gliomas and metastic brain tumors. The company is based in Richland, Washington.